Matching lymph node tests in breast cancer
Part of Cancer, Skin clinical trials.
This study looks back at past MRI scans and lymph node biopsies or surgeries in people with breast cancer to better understand how cancer spreads to the lymph nodes. If you had these tests as part of your care, your data might help improve future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had breast cancer that was stage I, II, or III.
- You had an MRI and a biopsy or surgery on the lymph nodes under your arm (axilla) as part of your diagnosis or treatment.
- You received chemotherapy or other drugs before surgery (neoadjuvant therapy) and have at least two MRI scans from before, during, or after that treatment (if you are part of the secondary analysis).
- Your MRI images were clear enough for the doctors to review.
- You have not had breast cancer before this diagnosis.
- You have not had surgery on the lymph nodes under your arm for any other reason before this breast cancer occurred.
- Your neoadjuvant therapy was given at the same hospital where the study is being done.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses MRI scans to predict if breast cancer has spread to additional lymph nodes beyond the first one that was biopsied. It may help women who have already had a positive sentinel lymph node biopsy and then had more lymph nodes removed.
This study uses a blood test and imaging to predict whether breast cancer has spread to underarm lymph nodes, helping guide surgery. It may reduce unnecessary lymph node removal.
This study uses images of your removed lymph nodes to see if cancer has spread there. It may help doctors better understand your cancer without needing extra tests.
This study uses multiple ultrasound methods to check the lymph nodes under the arm in people newly diagnosed with breast cancer. It aims to better understand the spread of cancer before surgery.
This study looks at whether substances called metabolites in your blood and breast tissue can help predict if breast cancer has spread to the first lymph node (sentinel node). If you are scheduled for breast cancer surgery and have not had prior treatment, the study team will use your blood and tissue samples to try to improve prediction.
This trial studies how doctors should operate on lymph nodes after you finish chemotherapy given before surgery. It may help improve treatment planning for people whose breast cancer has spread to nearby lymph nodes, but not to distant organs.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.